Prevalence and Clinical Characteristics of Androgenetic Alopecia in Nepalese Patients: A Cross-Sectional Observational Study

March 2023 in “ Civil Medical Journal ”

Prajwal Pudasaini, Sagar G.C, Eru Sujakhu, Manish Bhakta Pradhan, Bibechan Thapa, Elisha Shrestha, Rabi Bhatta, Sushil Paude

androgenetic alopecia AGA Norwood Hamilton scale COVID-19 male pattern baldness female pattern baldness

TLDR Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.

This study examined 304 male patients with androgenetic alopecia (AGA) in Nepal, with a mean age of 29 years. The most common AGA pattern was Norwood Hamilton type 3, followed by type 2. Notably, 1% of patients exhibited a female-type AGA pattern, where the frontal hairline was preserved. The average duration of AGA was 4 years, and 37% of participants had a history of COVID-19 infection, suggesting a potential link between COVID-19 and AGA exacerbation. The study highlights the need for a broader grading system for AGA, considering specific sub-classifications.

View this study on cmj.org.np →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

in Research 864 upvotes 4 months ago

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 6 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community How does hair loss and recovery work?

in Chat 12 upvotes 6 months ago

Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

community Follicum releases some data from previous phase 2a trial

in Research/Science 13 upvotes 1 year ago

Follicum discovered that their drug FOL-005 increased hair count by 12 hairs per cm2 in patients with less than 255 hairs per cm2 and is planning a phase 2b trial. They are currently fundraising for the trial, and the drug may also be effective for women.

community Let's be clear, does Finasteride stop MPB as long as it's taken?

in Finasteride/Dutasteride 170 upvotes 11 months ago

Finasteride is believed to slow down hair loss significantly, but may not completely stop it for everyone. Effectiveness and duration vary by individual, with some users experiencing positive results for over 10 years, while others see less benefit.

community Fats on your Head to Stop Hair Loss?

in Research/Science 140 upvotes 1 year ago

The conversation discusses the potential of long-chain unsaturated fatty acids, like oleic and linoleic acid, as an additional treatment for hair loss, which may inhibit the enzyme responsible for converting testosterone to DHT and promote hair growth. Users humorously suggest using oils topically and discuss other hair loss treatments, but the main focus is on the science behind fatty acids and their role in hair health.

Similar Research

5 / 1000+ results

research Association of Androgenetic Alopecia with a More Severe Form of COVID-19 Infection

1 citations, March 2022 in “Irish Journal of Medical Science”

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

research Androgenetic Alopecia and COVID-19: A Review of the Hypothetical Role of Androgens

9 citations, May 2021 in “Dermatologic Therapy”

Possible link between androgens and COVID-19 severity; more research needed.

research Patient-Reported Outcomes and Safety of Direct-to-Consumer Teledermatology for Finasteride in Male Androgenetic Alopecia

January 2023 in “DIGITAL HEALTH”

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

research The Probable Destructive Mechanisms Behind COVID-19 on Male Reproductive System and Fertility

17 citations, May 2021 in “Journal of Assisted Reproduction and Genetics”

COVID-19 may harm male fertility and damage the reproductive system.

Androgenetic Alopecia in Women and Men Is Not Related to COVID-19 Infection Severity: A Prospective Cohort Study of Hospitalized COVID-19 Patients

research Androgenetic Alopecia in Women and Men Is Not Related to COVID-19 Infection Severity: A Prospective Cohort Study of Hospitalized COVID-19 Patients

4 citations, May 2021 in “Journal of The European Academy of Dermatology and Venereology”

Hair loss doesn't affect COVID-19 severity.